Nordhealth AS (OSL:NORDH) Total Equity: kr651.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:NORDH Nordhealth AS OSL:NORDH
73 GF Score
Price kr22.40
GF Value kr39.15
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Nordhealth AS Total Equity?

Nordhealth AS OSL:NORDH +0.90% 73 Total Equity is kr651.2 Mil as of Mar. 2026. GuruFocus rates OSL:NORDH with a GF Score™ of 73/100 and a GF Value™ of kr39.15 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Nordhealth AS's total equity for the quarter that ended in Mar. 2026 was kr651.2 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Nordhealth AS Total Equity Historical Data

* Premium members only.

The historical data trend for Nordhealth AS's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nordhealth AS Total Equity Chart

Nordhealth AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial 1,162.02 1,032.28 952.16 865.11 728.53

Nordhealth AS Quarterly Data
Apr21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 831.47 790.25 763.31 728.53 651.24
OSL:NORDH
73GF Score
Nordhealth AS OSL:NORDH
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nordhealth AS Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Nordhealth AS's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=846.518-117.993
=728.5

Nordhealth AS's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=814.829-163.593
=651.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of kr651.2 Mil mean?
Nordhealth AS (OSL:NORDH) has a Total Equity of kr651.2 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Nordhealth AS and its competitors.
Is Nordhealth AS's Total Equity too high?
Nordhealth AS's current Total Equity is kr651.2 Mil. Overall, Nordhealth AS has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nordhealth AS's Total Equity compare to VEEV and BTSG?
Nordhealth AS's Total Equity of kr651.2 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Healthcare Providers & Services company?
A good Total Equity depends on the Healthcare Providers & Services industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Nordhealth AS and its competitors. Nordhealth AS's current Total Equity is kr651.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nordhealth AS stock overvalued right now?
Based on GuruFocus' analysis, Nordhealth AS (OSL:NORDH) is currently considered Significantly Undervalued. The stock's GF Value™ is kr39.15, compared to a current price of kr22.40 — trading 42.8% below its estimated fair value. The current Total Equity is kr651.2 Mil. Nordhealth AS's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Nordhealth AS (OSL:NORDH), the current Total Equity is kr651.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nordhealth AS (OSL:NORDH) Overvalued in 2026?

Based on GuruFocus' analysis, Nordhealth AS stock appears to be undervalued. The current stock price of kr22.40 is trading 42.8% below its estimated GF Value™ of kr39.15. GuruFocus considers Nordhealth AS to be Significantly Undervalued.

Key valuation signals for OSL:NORDH:

  • Total Equity: kr651.2 Mil
  • GF Value™: kr39.15 vs. price of kr22.40 (42.8% below fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the OSL:NORDH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nordhealth AS Business Description

Address Hasleveien 28A, Oslo, NOR, 0571
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship Practice Management Software (PMS), Provet for veterinary practices and Therapy Unified Platform for therapy practices, assist healthcare professionals to streamline operations and improve patient care. The majority of its revenue is generated through software subscriptions. The Group also offers additional services related to the implementation of the SaaS systems, including consultancy services, education, and data conversion. Its operating segments are: Veterinary, which generates the majority of revenue, Therapy, and Other. Geographically, Nordhealth derives maximum revenue from Norway, and the rest from Finland, the United Kingdom, Sweden, Denmark, the DACH region, and other countries.
73GF Score

Get the complete analysis for OSL:NORDH

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr22.40
Price
kr39.15
GF Value